Loading insider details...
Latest Form 4 (Oct 1, 2026): Grant/Award of 50,000 LRMR shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Oct 1, 2026 | Larimar Therapeutics, Inc. (LRMR) | Grant/Award | 50,000 | n/a |
| Jul 13, 2026 | Esperion Therapeutics, Inc. (ESPR) | Disposition to Issuer | 424,536 | n/a |
| Dec 8, 2025 | Esperion Therapeutics, Inc. (ESPR) | Grant/Award | 424,536 | n/a |